Patents Examined by Ali Soroush
  • Methods of controlling the breeding behavior of butterflies
    Patent number: 10362781
    Abstract: Methods of controlling the feeding and/or breeding behavior of a target insect are disclosed in which a host plant is provided a substantial distance from a plant of interest, chemical attractant that induces the target insect to lay eggs on the host plant is applied to the host plant, application of the chemical attractant to the host plant is repeated as required to induce residual target-insect populations to lay eggs on the host plant, and wherein the behavior is controlled when a substantial number of offspring belonging to subsequent generations themselves mature and display a preference for laying eggs on the same type of host plant on which they were reared without further application of the chemical attractant is provided. Also disclosed are methods of deterring target insect feeding and breeding on plants of interest by applying toxic plant extract to the plants of interest.
    Type: Grant
    Filed: July 16, 2015
    Date of Patent: July 30, 2019
    Assignee: University of the West Indies, a Regional Institution, established by Royal Charter
    Inventors: Trevor Herbert Yee, Charah Tabetha Watson, Eric Garraway
  • Macrostructure forming surfactants useful as spray drift control agents in pesticide spraying applications
    Patent number: 10357032
    Abstract: The present invention relates to an aqueous agrochemical spray solution containing an agrochemical active and a surfactant. The spray solution comprises a dispersed phase comprising dispersed particles which have an average particle size between 1 to 100 microns and the concentration of said dispersed particles is from about 0.001 to 5 wt %. The aqueous agrochemical spray solution is capable of reducing the volume of the fine droplets in mist whose size is less than 150 microns during spraying by at least 20% compared to the same aqueous spray solution without the presence of the surfactant. The present invention also relates to a method of reducing the spray drift of an aqueous agrochemical spray solution upon spraying with a spraying apparatus. The method includes adding the surfactant to the aqueous agrochemical spray solution in an amount effective to form the dispersed phase.
    Type: Grant
    Filed: January 12, 2018
    Date of Patent: July 23, 2019
    Assignees: AKZO NOBEL CHEMICALS INTERNATIONAL B.V., DOW AGROSCIENCES LLC
    Inventors: Jinxia Susan Sun, Shawn Zhu, Martin W. Murray, Marcus Boone, Michael Walters, Qingwen Wendy Yuan-Huffman, Christine Puglisi, Brandon Matthew Downer, Stephen L. Wilson
  • Hyaluronic acid-based gels including lidocaine
    Patent number: 10328180
    Abstract: Disclosed herein are soft tissue fillers, for example, dermal and subdermal fillers, based on hyaluronic acids and pharmaceutically acceptable salts thereof. In one aspect, hyaluronic acid-based compositions described herein include a therapeutically effective amount of at least one anesthetic agent, for example, lidocaine. The present hyaluronic acid-based compositions including lidocaine have an enhanced stability, relative to conventional compositions including lidocaine, for example when subjected to sterilization techniques or when stored for long periods of time. Methods and processes of preparing such hyaluronic acid-based compositions are also provided.
    Type: Grant
    Filed: June 6, 2016
    Date of Patent: June 25, 2019
    Assignee: Allergan Industrie, S.A.S.
    Inventor: Pierre F. Lebreton
  • Cosmetic composition containing 3-O-alkyl-L-ascorbic acid or salt thereof
    Patent number: 10322078
    Abstract: The present invention provides a cosmetic composition containing (A) 3-O-alkyl-L-ascorbic acid wherein the alkyl group has 8-12 carbon atoms or a salt thereof, (B) one or more kinds of nonionic surfactants selected from the group consisting of polyoxyethylene polyoxypropylene alkyl ether, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene alkyl ether and polyoxyethylene alkenyl ether, and having an HLB value of 12.5-17, and (C) one or more kinds of oil agents selected from the group consisting of amino acid ester, dimer acid ester, hydroxy acid ester, alkyl glyceryl ether and alkenyl glyceryl ether, which is superior in solubilization stability, preservation stability and sense of use, and free of time-dependent development of an odor which poses a problem when in use.
    Type: Grant
    Filed: December 9, 2016
    Date of Patent: June 18, 2019
    Assignee: AJINOMOTO CO., INC.
    Inventor: Mandai Yamada
  • Hair grooming implement cleaning solution
    Patent number: 10314310
    Abstract: A new composition and method for cleaning hair grooming implements is provided. The composition comprises about 1.1% Sodium Hypochlorite, about 2.5% Sodium Hydroxide, about 0.5% Lithium Perchlorate and about 95.9% water. A concentrated version of the solution may be formed and later diluted for use.
    Type: Grant
    Filed: April 13, 2016
    Date of Patent: June 11, 2019
    Assignee: ZAE PRODUCTS & SERVICES LLC
    Inventors: Zoraida Encarnacion, Jiangyin Bao, Hansini Mundigala
  • Compositions containing anthraquinone derivatives as growth promoters and antifungal agents
    Patent number: 10299474
    Abstract: Compositions for modulating plant growth, seed germination and soil borne diseases comprising anthraquinone derivatives are disclosed.
    Type: Grant
    Filed: January 6, 2014
    Date of Patent: May 28, 2019
    Assignee: Marrone Bio Innovations, Inc.
    Inventors: Hai Su, Pamela Marrone
  • Composition for external use preparation with improved transdermal permeability
    Patent number: 10292955
    Abstract: Provided is a skin external composition, which includes tranexamic acid or a salt thereof and a skin penetration enhancer, thereby showing remarkably increased skin permeability and improved sense of use, skin irritation, and storage stability.
    Type: Grant
    Filed: March 28, 2014
    Date of Patent: May 21, 2019
    Assignee: HYUNDAI PHARM CO., LTD.
    Inventors: Dong il Lee, Min ji Yoon, Pung Sok Lee
  • Opioid and attention deficit hyperactivity disorder medications possessing abuse deterrent and anti-dose dumping safety features
    Patent number: 10183001
    Abstract: An abuse deterrent drug product is provided wherein the drug product comprises a matrix and a drug substance in the matrix wherein the drug substance is defined as a 1:1 salt of a pharmaceutically active compound and BNDO.
    Type: Grant
    Filed: December 18, 2015
    Date of Patent: January 22, 2019
    Assignee: Pisgah Laboratories, Inc.
    Inventors: Clifford Riley King, Stephen G. D'Ambrosio, David W. Bristol
  • Stabilized formulations of CNS compounds
    Patent number: 10149853
    Abstract: Formulations of molindone having superior stability and methods of administering same are provided. The formulations may be immediate, modified, or otherwise delayed release formulations of molindone.
    Type: Grant
    Filed: April 25, 2014
    Date of Patent: December 11, 2018
    Assignee: SUPERNUS PHARMACEUTICALS, INC.
    Inventors: Rong-Kun Chang, Michael L. Vieira, Likan Liang, Padmanabh P. Bhatt, Austin B. Huang, Sachin V. Patel
  • Spray drift reduction agents comprising low hydrophilic-lipophilic balance surfactants
    Patent number: 10123532
    Abstract: Embodiments of the present invention disclose using low hydrophilic-lipophilic balance surfactants as spray drift reduction agents and methods of using such agents.
    Type: Grant
    Filed: January 4, 2016
    Date of Patent: November 13, 2018
    Assignee: HUNTSMAN PETROCHEMICAL LLC
    Inventor: Curtis M. Elsik
  • Use of arsenic compounds for treatment of pain and inflammation
    Patent number: 10058570
    Abstract: The present invention relates to the use of arsenic compounds such as sodium meta arsenite (NaAsO2), arsenic trioxide (As2O3), and arsenic hexoxide (As4O6) or combinations thereof, for the treatment of painful, hyperalgesic and/or inflammatory conditions. The present invention also relates to compositions containing the above arsenic compounds for use in the treatment of pain, inflammation and immunological and autoimmune diseases and disorders.
    Type: Grant
    Filed: April 24, 2013
    Date of Patent: August 28, 2018
    Assignee: Panaphix Inc.
    Inventors: Michael Hwang, Yong Jin Yang
  • Pharmaceutical composition containing clomipramine and preparation method therefor
    Patent number: 10045944
    Abstract: The present invention provides a pharmaceutical formulation comprising clomipramine or its pharmaceutically acceptable salt (preferably, clomipramine hydrochloride) as the first active ingredient, and sildenafil or its pharmaceutically acceptable salt (preferably, sildenafil citrate) as the second active ingredient, wherein stability of clomipramine is improved, and a method for manufacturing this pharmaceutical formulation. In particular, the present invention provides a pharmaceutical formulation comprising the above two active ingredients and manufactured by using a wet granulation method, wherein stability of clomipramine is improved, and a method for manufacturing this pharmaceutical formulation.
    Type: Grant
    Filed: December 29, 2014
    Date of Patent: August 14, 2018
    Assignee: CTC BIO, INC.
    Inventors: Hong Ryeol Jeon, Bong-Sang Lee, Seong-Shin Kwak, Dong-Jin Lee, Hyun-Jung Park, Jung-Hwa Kim
  • Composition, and method of using the composition, effective for minimizing the harmful effects associated with individuals suffering from alcohol intoxication
    Patent number: 10028991
    Abstract: The present invention relates to a composition, and methods of using the composition, for minimizing the harmful effects associated with alcohol consumption. The composition includes a plurality of ingredients, which when combined, have the unexpected effect of increasing one or more metabolic pathways in the individual. As the metabolic rate is increased, alcohol is burned off, or utilized as energy source, and occurs at a considerably much faster rate than under normal physiological means. It is believed that the composition may have an effect on the brain causing it to increase metabolic rates. By administering the composition to an inebriated individual, the rate at which a person sobers up, occurs at a faster rate than would occur under normal physiological time frames.
    Type: Grant
    Filed: November 5, 2015
    Date of Patent: July 24, 2018
    Assignee: GDB Patent Holdings, LLC
    Inventor: Gregory Blackman
  • Tricalcium phosphates, their composites, implants incorporating them, and methods for their production
    Patent number: 10011486
    Abstract: Methods for the synthesis of tricalcium phosphates are presented, as well as a series of specific reaction parameters that can be adjusted to tailor, in specific ways, properties in the tricalcium phosphate precursor precipitate. Particulate tricalcium phosphate compositions having an average crystal size of about 250 nm or less are provided. Compositions of the invention can be used as prosthetic implants and coatings for prosthetic implants.
    Type: Grant
    Filed: November 7, 2016
    Date of Patent: July 3, 2018
    Assignee: Pioneer Surgical Technology, Inc.
    Inventor: Edward S. Ahn
  • Diversion-resistant microgranules and microtablets
    Patent number: 9993431
    Abstract: The invention relates to the use of an oral dosage form based on microgranules and/or microtablets to reduce the abusive use of at least one active principle contained therein. The aim of the invention is to prevent the diversion of an oral dosage form based on microgranules and/or microtablets containing at least one active principle capable of causing a dependency, a gelling agent, and a gelling activator. The gelling agent and the activator are only brought into contact with each other in the event of diversion by crushing. Said judiciously selected pair of excipients confers a viscosity to the formulation, such that said formulation cannot be administered by injection or does not release the active principle rapidly by forming a gel when it comes into contact with the mucous membrane if nasally administered.
    Type: Grant
    Filed: June 7, 2011
    Date of Patent: June 12, 2018
    Assignee: Ethypharm
    Inventor: Vincent Billoet
  • Composition comprising a biological control agent and a fungicide selected from inhibitors of the lipid membrane synthesis, the melanine biosynthesis, the nucleic acid synthesis or the signal transduction
    Patent number: 9968097
    Abstract: The present invention relates to a composition comprising at least one biological control agent. Furthermore, the present invention relates to the use of this composition as well as a method for reducing overall damage of plants and plant parts.
    Type: Grant
    Filed: May 29, 2013
    Date of Patent: May 15, 2018
    Assignee: Bayer CropScience AG
    Inventors: Ulrike Wachendorff-Neumann, Wolfram Andersch, Klaus Stenzel, Bernd Springer
  • Antimicrobial colloidal silver products and method of making same
    Patent number: 9936704
    Abstract: Gelatinous materials combined with the Colloidal Silver additive to formulate an antimicrobial product having cushioning properties. Embodiments of the present invention can include gelatinous materials selected from a group consisting of thermosetting polymer, Styrene-Ethylene-Butadiene-Styrene polymer (SEBS), Thermoplastic Elastomer (TPE), and Polyurethane (PU) gelatin with and without a raised geometry on an outer surface.
    Type: Grant
    Filed: December 29, 2014
    Date of Patent: April 10, 2018
    Inventor: Thomas P. Davis
  • Phosphodiesterase 4 inhibitors for cognitive and motor rehabilitation
    Patent number: 9931318
    Abstract: The present invention provides methods of improving cognitive and motor deficits associated with central nervous system (CNS) disorder or condition in an animal. The methods comprise a general administration of phosphodiesterase 4 inhibitors and optionally training the animal under conditions sufficient to produce an improvement in performance.
    Type: Grant
    Filed: March 3, 2008
    Date of Patent: April 3, 2018
    Assignee: DART NEUROSCIENCE (CAYMAN) LTD.
    Inventors: Thomas M. Hallam, Tim Tully, Rusiko Bourtchouladze
  • Compositions and methods for treating bacterial infection
    Patent number: 9925206
    Abstract: Compositions and methods of utilizing the same are provided for treating bacterial infections. The compositions comprise acidified nitrite in combination with an iron chelator and an antibiotic. The compositions of the present invention are effective at treating bacterial infections with minimal to no side effects. Surprisingly, the combination of these three agents has a synergistic effect, which advantageously permits a lower dose of one or more of the active agents (e.g., the antibiotic).
    Type: Grant
    Filed: March 10, 2016
    Date of Patent: March 27, 2018
    Assignee: UNIVERSITY OF CINCINNATI
    Inventor: Daniel J. Hassett
  • Product and method of deploying kale derivatives for anti-cancer effects
    Patent number: 9919016
    Abstract: The present disclosure describes chemopreventative and/or chemotherapeutic compositions for inducing apoptosis in cancer cells which include kale and methods of inducing apoptosis in cancer cells utilizing the chemopreventative and/or chemotherapeutic compositions including kale.
    Type: Grant
    Filed: February 10, 2016
    Date of Patent: March 20, 2018
    Inventors: Bilal Qizilbash, Elizabeth Brandon